Professional journals serve as critical avenues to promote communication of new research findings and syntheses of scientific information throughout the medical community. There can be a delay, however, in the application of such scientific information to actual clinical practice. In the field of integrative cancer care, this normal delay is complicated by the implementation of many techniques of alternative, complementary, and traditional medicine before scientific validation. Both of these patterns can leave the practitioner scrambling to understand new trends in the field. To begin to address the problem of advancing clinical practice and understanding in integrative cancer care, this journal is offering an article series that we call the Integrative Tumor Board.
The Integrative Tumor Board in Integrative Cancer Therapies is a forum unique among journal-based tumor boards. It is modeled on the activities of a hospital tumor board but is based on an integrative cancer medicine perspective. In typical tumor boards, a physician will present standard clinical data on a case, and several medical specialists will then comment on the case from their own perspectives. The unique feature of the Integrative Tumor Board is that in addition to comments from medical specialists, practitioners of a variety of complementary, alternative, and integrative disciplines will also give their analyses of each case. Final comments will be made at the end of the practitioner contributions, pointing out particularly interesting features or raising issues or concerns; comments are supervised by the journal's editor-in-chief in consultation with experts in several relevant disciplines. Integrative Tumor Boards will be presented in most or all issues of Integrative Cancer Therapies; they will be composed of recommendations of rotating panels of medical specialists and other practitioners.
It is important that the reader understand some of the basic premises of the Integrative Tumor Board: Board articles should not be construed as endorsements of these interventions by the journal's editorial staff or members of any of its editorial boards. We do not expect readers to agree with all Tumor Board recommendations. Specific problem areas in Tumor Board suggestions will be noted in the comments, especially in areas that might pose potential risks; we will not, however, discuss every area of disagreement. 2. Recommendations in the Integrative Tumor Board are not presented as an example of how patients should be treated from an integrative medicine perspective. Actual treatment at an integrative clinic requires regular interaction and exchange among the cooperating practitioners and overall supervision by a physician who is aware of the potential contributions of the various disciplines represented in the clinic. The Integrative Tumor Board is, rather, a venue to present perspectives of a variety of disciplines important in integrative cancer care in a public forum. Its purpose is to promote knowledge and understanding of these perspectives by all health professionals working with cancer patients, since the majority of cancer patients currently are taking advantage of 1 or more integrative therapies. We will try to encourage important areas of synergy and point out potential negative interactions (eg, drug-herb interactions), recognizing that adequate management of both is fundamental to truly integrative care. However, this is not easily accomplished when practiced within a single facility, let alone when bringing together many modalities from several different practitioners. Still, we will attempt to address as best we can the more relevant interrelationships.
Not all of the suggestions made in Integrative Tumor
Board articles will be solidly evidence based, particularly since some aspects of integrative care fall into a category one might call intangibles. Still, we are encouraging integrative practitioners to make an attempt to anchor suggestions in scientific evidence, or at least to submit suggestions that are not unreasonable from a scientific or psychological viewpoint, or from a traditional medicine perspective in the articles submitted by practitioners from various schools of traditional medicine. 4. We expect that the many evidence-based or scientifically reasonable suggestions in Integrative Tumor Board articles will be viewed with seriousness even by readers accustomed to working in a conventional medicine perspective. Such readers may be startled, however, by some of the less evidence based suggestions, or by the spiritual counseling that will be offered by some practitioners. Conventionally oriented health professionals should realize that their cancer patients may indeed be seeing practitioners who work from less evidence-based perspectives. We strongly feel both that this is a relevant aspect of integrative care and that it is important that health professionals understand the nature of such perspectives, and some of the potentially healthful (or unhealthful) practices they prescribe. This is essential information for those electing to work constructively with patients who are using practices of alternative, complementary, and traditional medicine in coping with their illnesses. 5. As will become evident in the Case Presentation, the information given to contributing practitioners is the clinical data obtained before counseling the patient on an integrative intervention. The initial case also may include information on lifestyle and psychosocial issues of the patient taken from a comprehensive questionnaire administered at the clinic of the presenting physician; details of some of this information from the actual patient, or the clinical information, may be changed to enable a clearer and more focused discussion or to promote elaboration of certain issues. Many laboratory analyses, and all traditional medicine diagnostic techniques, are absent from the presentation. This limits the ability of practitioners to make specific recommendations for the patient, as several have noted. In response, however, most of the practitioners have made their own recommendations for laboratory analyses and other diagnostic techniques. In these recommendations, one can perceive the types of clinical analysis used in each discipline included in the Integrative Tumor Boardinformation that is surely as useful as specific clinical suggestions in developing an understanding of integrative approaches to cancer.
Many readers will find the volume of information included in the Tumor Board articles overwhelming. This reaction is, in fact, typical of those attending hospital tumor boards as well. We also feel that it is true that integrative care itself can seem overwhelming to both practitioners and patients, particularly those just beginning their encounters with the field. This is not an irrelevant issue when working with patients already facing circumstances surrounding their illness and treatments that are burdensome in and of themselves. As we have found in patient care, and as we trust will occur with those of you new to integrative cancer treatment, you will become more familiar with the various practices that will be included in the Integrative Tumor Board, and this sense of being submerged in information will diminish. We hope that the Tumor Board series will advance comprehension of both the conventional medical interventions and the complementary, alternative, and traditional medicine interventions on the part of health professionals and patients as this new approach to cancer care grows and develops.
Recurrent Carcinoma of Ovary

Case Presentation
Presenting complaint: A 61-year-old female, 14 months since completion of chemotherapy for stage IIC serous papillary cystadenocarcinoma of right ovary, asymptomatic, with sudden elevation of CA-125 (91 U/mL) and computed tomography (CT) scan of abdomen and pelvis negative except for an enlarged single external iliac lymph node.
History of present illness:
The patient's recent history dates back to October 2000, when she had a colonoscopy after complaints to her primary care physician of vague, lower abdominal pain. Colonoscopy detected extrinsic pressure on the cecum. A CT scan of the abdomen and pelvis month demonstrated a large, right cystic pelvic and solid mass with septations. CA-125 was 145 U/mL. In November 2000, the patient underwent an exploratory and staging laparotomy that revealed a 19 × 13 × 10 cm right ovarian mass. The surgical procedure included pelvic/abdominal washings, bilateral salpingo-oophorectomy, omentectomy, appendectomy, bilateral pelvic lymph node sampling, and multiple pelvic and abdominal peritoneal biopsies (patient status post-hysterectomy many years prior for benign reason). Final surgical pathology reported a right ovarian serous papillary cystadenocarcinoma, grade III, confined to the ovary without surface extension. Both fallopian tubes and the left ovary were without tumor involvement. Bladder and rectosigmoid pelvic peritoneal biopsies demonstrated small foci of infiltrating serous papillary cystadenocarcinoma. Right diaphragm, right and left colic and pelvic washings revealed positive cytology (malignant cells). The patient was staged as IIC (T2C N0 M0). The patient had an uneventful postoperative recovery.
Medical oncology consultation noted high-risk recurrence rate and recommended 6 cycles of paclitaxel and carboplatin administered every 21 days for 6 cycles. The patient underwent this treatment without event. CA-125 returned to within the normal range (below 35 U/mL) after the first course of chemotherapy. The patient has been asymptomatic since completion of treatment, with regular medical and gynecologic oncology physical examinations. CA-125 performed every 3 months has been within the normal range.
Past medical history: Mild hypertension treated with diet and weight reduction. Mild to moderate obesity. Never pregnant.
Past surgical history:
Abdominal hysterectomy in 1987 for recurrent, abnormal bleeding.
Medications: None.
Allergies: No known drug allergies.
Family history: Patient has 1 brother alive and well at age 55. The patient was born in Egypt but has lived in the United States for many years.
Social history:
The patient admits to occasional smoking (never more than several cigarettes per day). She denies alcohol use and drinks 1 to 2 cups of caffeinated coffee per day. The patient is not married.
Review of systems:
The patient currently has no referable symptoms. The patient was only symptomatic at her initial evaluation in October 2000, which prompted colonoscopy and CT scan of the abdomen and pelvis. The patient states she has always been overweight. Eyes, ears, nose, and throat: no allergies. Respiratory: denies chest pain; shortness of breath or cough. Cardiovascular: no chest pain, dyspnea on exertion, or lower extremity swelling. Gastrointestinal: no decrease in or loss of appetite. No heartburn or reflux. Bowels regular. Genitourinary: no urinary or gynecologic complaints. Neurologic: no headaches, syncopal episodes, or localizing signs. Musculoskeletal: no symptoms.
Dietary history: Childhood diet of typical Egyptian food. American diet for many years. The patient admits to obesity secondary to overeating when stressed.
Exercise history: Patient walks regularly but denies other exercise.
Supplemental history:
The patient takes a nonprescription multivitamin.
Emotional stress factors:
The patient worked in an executive position for a major, international airline for many years with high daily stress.
Physical exam:
The patient is a well-developed, alert, obese female in no acute distress.
Vital signs: blood pressure 150/84; pulse rate 78; respiratory rate 18; afebrile; weight 209 lb; height 5′4″.
